AI-generated summary
The authors describe a planned randomized, placebo-controlled trial of photobiomodulation combined with a static magnetic field for chronic non-specific knee pain in 86 adults. Participants will receive active or placebo treatment three times weekly for four weeks, with pain intensity as the primary outcome. As a protocol, the study reports no results yet.
- Participants
- 86
- Who or what was studied
- Adults aged 18 to 50 years with chronic, unilateral, non-specific knee pain
- Wavelengths
- 905, 850, 640 nm
- Limits stated in the abstract
- As a trial protocol, the abstract reports no outcome results and the authors state that high-quality clinical evidence in this population is scarce.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 905 nm, 850 nm, 640 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Laser, Visual analogue scale, Trial registration, Oxidative stress, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.